Home

תיאור עסקי להיתמודד עם חליפין j bioorg med chem lett מפואר האי סטיוארט מטושטש

Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and  Guiding Principles for Industrial Authors
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors

名古屋大学大学院創薬科学研究科 天然物化学分野
名古屋大学大学院創薬科学研究科 天然物化学分野

Identification and Structure-Guided Development of Pyrimidinone Based USP7  Inhibitors | ACS Medicinal Chemistry Letters
Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors | ACS Medicinal Chemistry Letters

Bioorganic & Medicinal Chemistry Letters | Journal | ScienceDirect.com by  Elsevier
Bioorganic & Medicinal Chemistry Letters | Journal | ScienceDirect.com by Elsevier

Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and  Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry

PDF) Corrigendum to 'Synthesis and biological evaluation of  Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett.  29/10 (2019) 1246–1255]
PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]

CCHF | Publication
CCHF | Publication

Bioorganic
Bioorganic

Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and  Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry

PDF) 2-Alkyl/alkenyl substituted pyridine C-region analogues of  2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1  antagonists
PDF) 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists

Portfolio of hits — Laboratory of Medicinal Chemistry — Ghent University
Portfolio of hits — Laboratory of Medicinal Chemistry — Ghent University

Fragment-to-Lead Medicinal Chemistry Publications in 2017 | Journal of Medicinal  Chemistry
Fragment-to-Lead Medicinal Chemistry Publications in 2017 | Journal of Medicinal Chemistry

名古屋大学大学院創薬科学研究科 天然物化学分野
名古屋大学大学院創薬科学研究科 天然物化学分野

Publications & Patents - The Trippier Lab
Publications & Patents - The Trippier Lab

PROTAC Technology: Opportunities and Challenges | ACS Medicinal Chemistry  Letters
PROTAC Technology: Opportunities and Challenges | ACS Medicinal Chemistry Letters

PDF) Corrigendum to “Discovery and SAR of  2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk  inhibitors” [Bioorg. Med. Chem. Lett. 16 (2006) 2411–2415] | Tai-An Lin -  Academia.edu
PDF) Corrigendum to “Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors” [Bioorg. Med. Chem. Lett. 16 (2006) 2411–2415] | Tai-An Lin - Academia.edu

Bioorganic & Medicinal Chemistry Letters | Vol 16, Issue 6, Pages 1451-1758  (15 March 2006) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 16, Issue 6, Pages 1451-1758 (15 March 2006) | ScienceDirect.com by Elsevier

PDF) Design, synthesis, and preliminary biological evaluation of novel  ethyl 1-(2 '-hydroxy-3 '-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate
PDF) Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2 '-hydroxy-3 '-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate

PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties  of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett.  26 (2016) 5867–5870]
PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]

Publications – Santos Lab
Publications – Santos Lab

成果及论文 - 南华大学王震课题组
成果及论文 - 南华大学王震课题组

Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 7, Pages 1357-1654  (1 April 2015) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 7, Pages 1357-1654 (1 April 2015) | ScienceDirect.com by Elsevier

Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and  Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry

Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs |  ACS Medicinal Chemistry Letters
Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs | ACS Medicinal Chemistry Letters

Targeting IRAK4 for Degradation with PROTACs | ACS Medicinal Chemistry  Letters
Targeting IRAK4 for Degradation with PROTACs | ACS Medicinal Chemistry Letters

PDF) Corrigendum to “Pyridine containing M1 positive allosteric modulators  with reduced plasma protein binding” [Bioorg. Med. Chem. Lett. 20 (2010)  657] | Lei Ma - Academia.edu
PDF) Corrigendum to “Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding” [Bioorg. Med. Chem. Lett. 20 (2010) 657] | Lei Ma - Academia.edu

Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 17, 1 September  2020 | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 17, 1 September 2020 | ScienceDirect.com by Elsevier